Urothelial carcinoma
Conditions
Interventions
Urothelial group:none
Sponsors
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18-80 years 2. Patients with urothelial carcinoma 3. ECOG 0-2 score 4. The subjects voluntarily joined the study, signed informed consent, had good compliance, and cooperated with follow-up
Exclusion criteria
Exclusion criteria: 1. Complicated with other malignant tumors 2. History of treatment for urothelial carcinoma, such as surgery, chemotherapy or immunotherapy 3. Abnormal mental ability to cooperate 4. Obvious abnormality of heart, lung, liver and kidney function, lack of compensatory function, or serious systemic diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive rate of circulating tumor cells; | — |
Secondary
| Measure | Time frame |
|---|---|
| positive rate of circulating tumor cells in patients with different stages of urothelial carcinoma; | — |
Countries
China
Contacts
Public ContactNianzeng Xing
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Outcome results
None listed